Clinical Trial Update: Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of KAI-9531 in adults with obesity or overweight and weight-related comorbidities who do not have diabet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• KAI-9531

Snippet

Sponsor: Kailera | Conditions: Obesity, Overweight | Phase 3 | Status: RECRUITING